Last reviewed 2026-04-22 · How we verify

Placebo patchs

Placebo patches deliver no active pharmaceutical ingredient, producing therapeutic effects primarily through placebo response mechanisms.

Placebo patches deliver no active pharmaceutical ingredient, producing therapeutic effects primarily through placebo response mechanisms. Used for Clinical research control/comparator in randomized controlled trials, Conditions responsive to placebo effects (pain, nausea, fatigue).

At a glance

Mechanism of action

Placebo patches are inert transdermal formulations used in clinical research and some therapeutic contexts to elicit placebo responses. They work through psychological and psychosomatic mechanisms, including expectation, conditioning, and the ritual of treatment administration, rather than through direct pharmacological action on molecular targets.

Approved indications

• Clinical research control/comparator in randomized controlled trials
• Conditions responsive to placebo effects (pain, nausea, fatigue)

Common side effects

• Skin irritation at application site
• Adhesive-related dermatitis

Key clinical trials

• Menopausal Hormones and Sympathetic Activation (PHASE4)
• Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic Amenorrhea (PHASE3)
• NEUROCUPLE™ as an Opioid Alternative Following Total Knee Arthroplasty (NA)
• Defining Neurobiological Links Between Substance Use and Mental Illness (NA)
• Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers) (PHASE3)
• Exenatide for Smoking Cessation and Prevention of Weight Gain (PHASE2)
• Estradiol Supplementation and Rotator Cuff Repair (PHASE2)
• Combination Gerotherapeutic Interventions for Healthspan Improvement (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.